Lv7
4390 积分 2021-08-31 加入
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial
19天前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
19天前
已完结
Clinicopathologic Correlations in a Series of 143 Patients with IgA Glomerulonephritis
19天前
已完结
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
19天前
已完结
A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy
19天前
已完结
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
19天前
已完结
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
19天前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
19天前
已完结
皖公网安备34019202002308
